Comparison of labor analgesia efficacy between single-orifice and multiorifice wire-reinforced catheters during programmed intermittent epidural boluses: a randomized controlled clinical trial. Issue 2 (9th November 2022)
- Record Type:
- Journal Article
- Title:
- Comparison of labor analgesia efficacy between single-orifice and multiorifice wire-reinforced catheters during programmed intermittent epidural boluses: a randomized controlled clinical trial. Issue 2 (9th November 2022)
- Main Title:
- Comparison of labor analgesia efficacy between single-orifice and multiorifice wire-reinforced catheters during programmed intermittent epidural boluses: a randomized controlled clinical trial
- Authors:
- Yi, Juan
Li, Yujie
Yuan, Yawei
Xu, Zhendong
Song, Yujie
Ye, Binglu
Zhao, Qingsong
Yang, Yingying
Du, Weijia
Liu, Zhiqiang - Abstract:
- Abstract : Aims: We compared analgesic outcomes between single-orifice and multiorifice wire-reinforced catheters under 480 mL/hour delivery rate with programmed intermittent epidural bolus administration. Methods: Between August and November 2021, 182 nulliparous and healthy women with singleton pregnancy, 2–5 cm cervical dilation, and requesting neuraxial analgesia were randomized to receive either single-orifice or multiorifice catheters. Epidural analgesia was initiated and maintained with 0.1% ropivacaine and 0.3 µg/mL sufentanil. Programmed intermittent epidural bolus volume of 10 mL was administered every 45 min at 480 mL/hour beginning immediately after the test dose. Primary outcome was the percentage of parturients in the two groups with adequate analgesia 20 min after the initial bolus. Results: Compared with multiorifice catheters, single-orifice catheters were associated with a higher proportion of parturients with adequate analgesia (71.8% vs 56.0%, respectively; 95% CI 1.3% to 29%, p=0.03) and more frequent S2 sensory blockade (37.6% vs 22.6%, respectively; 95% CI −30% to 1%, p=0.03) 20 min after block initiation. Median time (IQR) to adequate analgesia was 12 (8–30) min and 20 (10–47) min with single-orifice and multiorifice catheters, respectively (95% CI 0.1 to 0.7 min, p<0.01). The median (IQR) ropivacaine consumption per hour was higher in parturients receiving multiorifice catheters than those with single-orifice catheters (15.3 (13.3–17.0) mg/hour vsAbstract : Aims: We compared analgesic outcomes between single-orifice and multiorifice wire-reinforced catheters under 480 mL/hour delivery rate with programmed intermittent epidural bolus administration. Methods: Between August and November 2021, 182 nulliparous and healthy women with singleton pregnancy, 2–5 cm cervical dilation, and requesting neuraxial analgesia were randomized to receive either single-orifice or multiorifice catheters. Epidural analgesia was initiated and maintained with 0.1% ropivacaine and 0.3 µg/mL sufentanil. Programmed intermittent epidural bolus volume of 10 mL was administered every 45 min at 480 mL/hour beginning immediately after the test dose. Primary outcome was the percentage of parturients in the two groups with adequate analgesia 20 min after the initial bolus. Results: Compared with multiorifice catheters, single-orifice catheters were associated with a higher proportion of parturients with adequate analgesia (71.8% vs 56.0%, respectively; 95% CI 1.3% to 29%, p=0.03) and more frequent S2 sensory blockade (37.6% vs 22.6%, respectively; 95% CI −30% to 1%, p=0.03) 20 min after block initiation. Median time (IQR) to adequate analgesia was 12 (8–30) min and 20 (10–47) min with single-orifice and multiorifice catheters, respectively (95% CI 0.1 to 0.7 min, p<0.01). The median (IQR) ropivacaine consumption per hour was higher in parturients receiving multiorifice catheters than those with single-orifice catheters (15.3 (13.3–17.0) mg/hour vs 13.3 (13.3–15.4) mg/hour, respectively; 95% CI 0.2 to 0.8 mg/hour, p<0.001). Conclusion: Single-orifice catheters used for programmed intermittent epidural bolus at 480 mL/hour for epidural labor analgesia had improved analgesic efficacy than multiorifice catheters. Trial registration number: ChiCTR2100049872. … (more)
- Is Part Of:
- Regional anesthesia and pain medicine. Volume 48:Issue 2(2023)
- Journal:
- Regional anesthesia and pain medicine
- Issue:
- Volume 48:Issue 2(2023)
- Issue Display:
- Volume 48, Issue 2 (2023)
- Year:
- 2023
- Volume:
- 48
- Issue:
- 2
- Issue Sort Value:
- 2023-0048-0002-0000
- Page Start:
- 61
- Page End:
- 66
- Publication Date:
- 2022-11-09
- Subjects:
- Obstetrics -- Pain Management -- analgesia
Conduction anesthesia -- Periodicals
Pain medicine -- Periodicals
617.964 - Journal URLs:
- http://www.rapm.org/ ↗
https://journals.lww.com/rapm/pages/default.aspx ↗
http://www.sciencedirect.com/science/journal/10987339 ↗
https://rapm.bmj.com/ ↗
http://journals.lww.com ↗ - DOI:
- 10.1136/rapm-2022-103723 ↗
- Languages:
- English
- ISSNs:
- 1098-7339
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 7336.572210
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 24768.xml